Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model

Lignende værker

• Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
  af: Aaron J Scott, et al.
  Udgivet: (2017-01-01)
• Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model
  af: Song, Eun-Kee, et al.
  Udgivet: (2014)
• Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
  af: Arcaroli, J J, et al.
  Udgivet: (2013)
• Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
  af: Bagby, Stacey, et al.
  Udgivet: (2016)
• Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer
  af: Arcaroli, John J., et al.
  Udgivet: (2010)